---
title: "Viracta Therapeutics closes NAVAL-1 trial and explores strategic options; Board of Directors initiates process to explore alternatives."
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/227577757.md"
description: "On December 26, 2024, a company called Viracta Therapeutics, Inc. (Nasdaq: VIRX), located in San Diego, revealed plans to evaluate various strategic alternatives. This clinical-stage precision oncology firm specializes in handling virus-related cancers affecting patients globally. The Board of Directors is spearheading this initiative to explore multiple options for the company's future direction and growth."
datetime: "2025-02-07T20:16:55.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/227577757.md)
  - [en](https://longbridge.com/en/news/227577757.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/227577757.md)
---

# Viracta Therapeutics closes NAVAL-1 trial and explores strategic options; Board of Directors initiates process to explore alternatives.

On December 26, 2024, a company called Viracta Therapeutics, Inc. (Nasdaq: VIRX), located in San Diego, revealed plans to evaluate various strategic alternatives. This clinical-stage precision oncology firm specializes in handling virus-related cancers affecting patients globally. The Board of Directors is spearheading this initiative to explore multiple options for the company's future direction and growth.

### Related Stocks

- [VIRX.US](https://longbridge.com/en/quote/VIRX.US.md)

## Related News & Research

- [INSTANT VIEW-SpaceX files long awaited IPO, creating a fresh AI play](https://longbridge.com/en/news/287124128.md)
- [SanDisk (SNDK) Has Surprised Me. I'm Still Not Buying the Stock Yet](https://longbridge.com/en/news/287177163.md)
- [Why Is Oklo Stock Surging On Wednesday?](https://longbridge.com/en/news/287096677.md)
- [Micron's stock gets a boost. Are Samsung's problems helping?](https://longbridge.com/en/news/287092903.md)
- [Inside The AI Chip Crunch: Intel Pressures PC Makers To Upgrade Fast](https://longbridge.com/en/news/287068550.md)